We are live on ! Find out more
ATXS

Astria Therapeutics

Delisted

ATXS was delisted on the 22nd of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$6.91M -$4.46M -678,455 -35%
RCM
2
RA Capital Management
Massachusetts
$6.8M
FFM
3
Fairmount Funds Management
Pennsylvania
$4.91M
CAM
4
Cormorant Asset Management
Massachusetts
$2.98M
VA
5
VR Adviser
New York
$2.9M
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.87M -$140K -21,330 -4%
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$1.48M +$329K +50,000 +22%
Citadel Advisors
8
Citadel Advisors
Florida
$1.2M -$580K -88,192 -28%
IC
9
Ikarian Capital
Texas
$473K
Geode Capital Management
10
Geode Capital Management
Massachusetts
$350K +$29.5K +4,484 +7%
BlackRock
11
BlackRock
New York
$287K +$78.6K +11,957 +29%
BCM
12
Bridgeway Capital Management
Texas
$243K +$296K +45,000 New
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$206K -$51.7K -7,863 -17%
Renaissance Technologies
14
Renaissance Technologies
New York
$185K -$493K -74,992 -69%
AG
15
Artal Group
Luxembourg
$180K
AI
16
ArchPoint Investors
Florida
$139K -$16.4K -2,500 -9%
SB
17
Samsara BioCapital
California
$135K
Northern Trust
18
Northern Trust
Illinois
$119K +$18.2K +2,760 +14%
OC
19
Oppenheimer & Co
New York
$118K +$62.9K +9,567 +78%
OQS
20
Occudo Quantitative Strategies
Florida
$83K
OWP
21
Old Well Partners
North Carolina
$65K
Wolverine Trading
22
Wolverine Trading
Illinois
$65K +$84.4K +12,836 New
Millennium Management
23
Millennium Management
New York
$55K +$67.5K +10,259 New
Bank of America
24
Bank of America
North Carolina
$21K +$17.3K +2,630 +206%
UBS Group
25
UBS Group
Switzerland
$18K +$1.57K +239 +8%